Our goal is to translate breakthrough science into innovation oncology medicines to help people with cancer worldwide. At Merck, the potential to bring new hope to people with cancer drives our purpose and supporting accessibility to our cancer medicines is our commitment. As part of our focus on cancer, Merck is committed to exploring the potential of immune-oncology with one of the largest development programs in the industry across more than 30 tumor types.
This content is intended only for health care professionals of the United States, its territories, and Puerto Rico.
Copyright ©2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. US-NON-05312 07/20